Tag Archives: harvoni

September, 2018

October, 2017

April, 2017

December, 2015

  • 2 December

    Hepatitis C Deaths Still On Rise

    The headlines are compelling when it comes to new medications for treating infection with the hepatitis C virus (HCV): Harvoni cures up to 98% of patients with genotype 1 HCV. Viekira Pak cures 100% of those with genotype 1b HCV. Sovaldi cures 95% of those with genotype 2 HCV. With …

November, 2015

  • 13 November

    FDA Expands Approval for Gilead’s Hepatitis C Drug

    FOSTER CITY, Calif.–(BUSINESS WIRE)–Nov. 12, 2015– Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved Harvoni® (ledipasvir/sofosbuvir) for expanded use in patients with genotype 4, 5 and 6 chronic hepatitis C virus (HCV) infection and in patients co-infected with HIV. In addition, …

September, 2015

  • 9 September

    Is Sicker Better?

    With a cure for hepatitis C finally in reach, it’s disheartening to learn that one in four hepatitis C patients hear a “no” the first time they seek treatment. According to Yale researchers, one-quarter of patients with chronic infection of the hepatitis C virus (HCV) are denied their first pre-authorization …

April, 2015

  • 7 April

    Value vs. Cost

    Ever since new (and admittedly high-cost) hepatitis C treatments hit the market, the price of curing hepatitis C has been under the microscope. News outlets repeatedly cite the $1,000 per pill price of Sovaldi or the $84,000 total price tag for the 12-week treatment course. So what are patients getting …

March, 2015

January, 2015

  • 9 January

    A Cure at a Lower Cost

    As 2015 arrives, it is wonderful to kick off the first blog of the new year with a story of hope. Last year, the excitement of newly approved hepatitis C virus (HCV) medications quickly morphed into cost concerns, as it became clear that these wonder cures came at a price …